Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Pulse Biosciences ( (PLSE) ).
Robert W. Duggan, the controlling stockholder and Co-Chairman of Pulse Biosciences, Inc., is considering buying up to 500,000 shares of the company’s common stock by December 2024. This move, approved under the company’s Insider Trading Policy, could potentially influence the market perception and value of Pulse Biosciences’ stock.
See more insights into PLSE stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue